The Controller General of Patents has issued first pharmaceutical product patent no. 198952 (the ‘952) to Swiss drug maker F. Hoffman-La-Roche for its biotech hepatitis drug Pegasys under the new patent regime paving way to reintroduction of product patent in India. However, any interested party may still challenge the ‘952 patent under post-grant provision (u/s 25(2)) within a year of grant of patent.
No comments:
Post a Comment